96 related articles for article (PubMed ID: 6100173)
1. Comparative experimental antibacterial activity of ceftriaxone (Ro 13-9904).
Böhni E
Chemioterapia; 1984 Feb; 3(1):25-32. PubMed ID: 6100173
[TBL] [Abstract][Full Text] [Related]
2. Rationale for clinical trials evaluating ceftriaxone in the therapy of bacterial meningitis.
Scheld WM; Rocha H; Sande MA; Bryan JP
Am J Med; 1984 Oct; 77(4C):42-9. PubMed ID: 6093518
[TBL] [Abstract][Full Text] [Related]
3. [Ceftriaxone, a long-acting cephalosporin. Microbiological, kinetic and clinical study].
Soranzo ML; Capra E; Angela GC; Eandi M; Salassa B; Lollini P; Musso E; Pizzo L; Spezia C; Di Nola F
Minerva Med; 1983 Sep; 74(36):2093-102. PubMed ID: 6312379
[TBL] [Abstract][Full Text] [Related]
4. [Long-term administration of ceftriaxone (Ro 13-9904) to complicated urinary tract infections].
Oishi K; Kawakita M; Hida S; Higashi Y; Yamauchi T; Yoshida O
Hinyokika Kiyo; 1985 Apr; 31(4):711-21. PubMed ID: 4036746
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of ceftazidime and ceftriaxone.
Keenholtz SL; Jacobus NV; Tally FP; Gorbach SL
Clin Ther; 1983; 5(6):603-16. PubMed ID: 6313195
[TBL] [Abstract][Full Text] [Related]
6. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)].
Nasnas R; Gutmann L; Kitzis MD; Goldstein F; Acar JF
Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385
[TBL] [Abstract][Full Text] [Related]
7. Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use.
Richards DM; Heel RC; Brogden RN; Speight TM; Avery GS
Drugs; 1984 Jun; 27(6):469-527. PubMed ID: 6329638
[TBL] [Abstract][Full Text] [Related]
8. [Cefotaxime, moxalactam and ceftriaxone: comparison of in vitro activity against hospital strains of Enterobacteriaceae belonging to the 4 principal phenotypes of sensitivity to beta-lactams].
Jarlier V; Bismuth R; Grosset J
Pathol Biol (Paris); 1983 May; 31(5):336-42. PubMed ID: 6312393
[TBL] [Abstract][Full Text] [Related]
9. Clinical and bacteriologic efficacy of ceftriaxone in the United States.
McCloskey RV
Am J Med; 1984 Oct; 77(4C):97-103. PubMed ID: 6093528
[TBL] [Abstract][Full Text] [Related]
10. [Quantitative study of the antibacterial effect of cefotaxime and ceftriaxone during experimental Escherichia coli K1 bacteremia in chickens].
Labarthe JC; Guillot JF; Mouline C; Bree A
Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):664-7. PubMed ID: 2677929
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of the therapeutic effect of cephalosporins in experimental endocarditis by altering their pharmacokinetics with diclofenac.
Joly V; Pangon B; Brion N; Vallois JM; Carbon C
J Pharmacol Exp Ther; 1988 Aug; 246(2):695-700. PubMed ID: 3042958
[TBL] [Abstract][Full Text] [Related]
12. Ceftriaxone: therapeutic results in various infections and kinetic studies.
Giamarellou HJ; Tsagarakis J; Petrikkos G; Mavroudis K; Veldekis D; Daikos GK
Arzneimittelforschung; 1984; 34(3):321-5. PubMed ID: 6329238
[TBL] [Abstract][Full Text] [Related]
13. [Comparative efficacy of ampicillin, chloramphenicol, cefotaxime, ceftriaxone and pefloxacin in experimental Salmonella typhimurium infection].
Nauciel C; Martin E
Pathol Biol (Paris); 1987 Nov; 35(9):1239-42. PubMed ID: 3320900
[TBL] [Abstract][Full Text] [Related]
14. Ceftriaxone therapy of meningitis and serious infections.
Steele RW
Am J Med; 1984 Oct; 77(4C):50-3. PubMed ID: 6093519
[TBL] [Abstract][Full Text] [Related]
15. Treatment of complicated urinary tract infections with the long acting cephalosporin, ceftriaxone.
Rothwell DL; Bremner DA; Taylor KM
N Z Med J; 1983 May; 96(732):392-4. PubMed ID: 6302612
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of beta-lactams against experimental pneumococcal endocarditis caused by strains with different susceptibilities to penicillin.
Pichardo C; Docobo-Pérez F; Pachón-Ibáñez ME; Jiménez-Mejías ME; García-Curiel A; Caballero-Granado FJ; Moreno-Maqueda I; Pachón J
J Antimicrob Chemother; 2005 Oct; 56(4):732-7. PubMed ID: 16150863
[TBL] [Abstract][Full Text] [Related]
17. Activity of Ertapenem and Ceftriaxone in the eradication of Salmonella in a model of experimental peritonitis in mice.
Lozano FS; García MI; García E; González B; García MB; García FJ; García JE
Rev Esp Quimioter; 2009 Sep; 22(3):135-8. PubMed ID: 19662546
[TBL] [Abstract][Full Text] [Related]
18. [The antibacterial activity of ceftriaxone and evaluation criteria for an agar diffusion test with ceftriaxone].
Grimm H
Wien Med Wochenschr Suppl; 1985; 87():3-8. PubMed ID: 3856974
[No Abstract] [Full Text] [Related]
19. Single-dose plasma and cerebrospinal fluid pharmacokinetics of ceftriaxone in infants and children.
Reed MD; Rekate HL; Aronoff SC; Myers CM; Blumer JL
Clin Pharm; 1983; 2(6):558-63. PubMed ID: 6317277
[TBL] [Abstract][Full Text] [Related]
20. Single daily dose treatment of severe refractory infections with ceftriaxone. Cost savings and possible parenteral outpatient treatment.
Baumgartner JD; Glauser MP
Arch Intern Med; 1983 Oct; 143(10):1868-73. PubMed ID: 6312914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
